Navigation Links
MonoSol Rx Completes Thin Film Escitalopram Oxalate Pilot Product Development
Date:8/4/2008

WARREN, N.J., Aug. 4 /PRNewswire/ -- MonoSol Rx, a specialty pharmaceutical company leveraging its proprietary drug delivery technology to develop thin film pharmaceutical products, today announced the completion of pilot product development for its thin film formulation of escitalopram oxalate, a selective serotonin reuptake inhibitor. Escitalopram oxalate is indicated for depression and generalized anxiety disorders and is marketed under the brand name Lexapro(R). Lexapro generated sales of $2.1 billion in 2007.

Based on product development results, the Company is preparing to initiate bioequivalence trials to support marketing submissions in the US and Europe.

A. Mark Schobel, president and chief executive officer of MonoSol Rx, stated, "Our completion of prototype development has advanced our thin film escitalopram oxalate product to the clinical investigation stage of the project. Our proprietary PharmFilm(R) technology delivers thin-film drug products designed to offer significant patient benefits over other currently marketed prescription drug products and will help ensure that patients receive the appropriate dose in all treatment settings.

The Company is currently exploring potential partnerships to market their thin film formulation of escitalopram oxalate and expects to solidify an agreement prior to global regulatory submissions. The PharmFilm(R) escitalopram oxalate product should be available for marketing ahead of generic entrants expected in 2012, when Lexapro(R) loses patent exclusivity in the United States.

Keith Kendall, chief financial officer for MonoSol Rx, commented, "Our thin film formulation of escitalopram oxalate is one of the Company's self- funded initiatives designed to capitalize on our capacity to develop and manufacture thin film prescription products at commercial scale for a large pharmaceutical partner. As blockbuster drugs lose exclusivity, pharmaceutical companies are exploring alternative dosi
'/>"/>

SOURCE MonoSol Rx
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study
2. Hyperion Therapeutics Completes Enrollment in Phase 1/2 Clinical Trial in Patients With Urea Cycle Disorders
3. NicOx Completes Enrollment of Two Ambulatory Blood Pressure Measurement (ABPM) Studies for Naproxcinod in Hypertensive OA Patients
4. VIA Pharmaceuticals Completes Patient Visits in Phase 2 Carotid Endarterectomy (CEA) Trial
5. Portola Completes $60 Million Financing to Advance Its Therapeutic Programs
6. Pulmo BioTech Inc. Completes Bio-Distribution Studies
7. Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles
8. Neurocrine Biosciences Completes Petal Study Treatment Phase for Endometriosis
9. Metabolex Completes Patient Enrollment in Phase 2 Trial of MBX-8025 for Treatment of Dyslipidemia
10. ChemoCentryx Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohns Disease
11. Pharmaxis Long-Term Safety Study of Bronchitol Completes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... We are living a connected life in a ... and very soon we will be able to connect our ... life market has been valued by Frost & Sullivan at ... drive and manage this change to stay ahead of the ... Highlights of the congress include a groundbreaking keynote address showcasing ...
(Date:4/27/2015)... 2015  MiMedx Group, Inc. (NASDAQ: MDXG ... amniotic tissue and patent-protected processes to develop and ... Care, Surgical, Orthopedic, Spine, Sports Medicine, Ophthalmic and ... results for the first quarter of 2015. ... decision of its Board of Directors to authorize ...
(Date:4/27/2015)... BOSTON , April 27, 2015   Intarcia ... $225 million synthetic royalty financing with an equity conversion ... to use these funds to accelerate the initiation of ... vs. leading oral and injectable type 2 diabetes therapies. ... expected infrastructure and talent required to launch ITCA 650 ...
Breaking Medicine Technology:Frost & Sullivan's GIL 2015 Unveils the $700 Billion Connected Life Market 2Frost & Sullivan's GIL 2015 Unveils the $700 Billion Connected Life Market 3MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 2MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 3MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 4MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 5MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 6MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 7MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 8MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 9MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 10MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 11MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 12MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 13MiMedx Announces Record Results for First Quarter of 2015 and raises full-year guidance 14Intarcia Therapeutics Closes Novel $225 Million Synthetic Royalty Financing With Equity Conversion Option At $5.5 Billion Valuation 2Intarcia Therapeutics Closes Novel $225 Million Synthetic Royalty Financing With Equity Conversion Option At $5.5 Billion Valuation 3
... at Society of NeuroInterventional Surgery ... ... results from,the US and Argentina reveal that a new minimally invasive ... condition that, in severe form, can cripple sufferers.,Announced today at the ...
... represents newest alternative surgical ... treatment, Dr. Carl Giordano - based in Morristown ... ... quicker recovery, MORRISTOWN, N.J., July 29 Leading New Jersey orthopedic,surgeon Dr. Carl ...
Cached Medicine Technology:New Minimally Invasive Surgical Procedure Restores Quality of Life in Patients With Potentially Debilitating Spinal Condition 2New Minimally Invasive Surgical Procedure Restores Quality of Life in Patients With Potentially Debilitating Spinal Condition 3NJ-Based Surgeon Helps Pioneer Dramatic Advance in Treating Damaged Discs 2
(Date:4/28/2015)... Louis, Missouri (PRWEB) April 28, 2015 ... report that delves into the reality problem Americans have ... the population will need long-term care services as they ... need such care. , In the report, Carol ... organizations such as the American Health Care Association and ...
(Date:4/28/2015)... Once considered an unproven alternative to HID lighting, the ... storm with perfectly tailored light spectrums in an ideal, low ... than half of every SuperCloset and SuperRoom sold are now ... is gone and LED Grow Lights are here to stay. ... their first hand experience using the new LED Grow lights ...
(Date:4/28/2015)... Omaha, NE (PRWEB) April 28, 2015 ... federal district are among the top areas that healthcare ... Medical Group, aureusmedical.com, during the month of March 2015. ... which specializes in travel nurse jobs , ... hire positions within nursing and allied health fields. ...
(Date:4/28/2015)... April 28, 2015 PREVENT Life Safety, ... announced the relocation of their Southern California offices from ... 9380 7th Street, Unit I (letter I), Rancho Cucamonga, ... relocation was necessitated by the significant growth the company ... California. PREVENT will continue to provide superior life safety ...
(Date:4/27/2015)... Healthcare marketing specialists Smith & ... “Website Anatomy 101.” Available for download at ... elements for a successful hospital website. , ... experience, search results and lead generation strategy, healthcare ... website on patient volume and retention. This white ...
Breaking Medicine News(10 mins):Health News:SeniorCare.com Report: America Has a Major Misconception on Aging 2Health News:SuperCloset Reports Surge in KIND LED Grow Light Sales, Saving Indoor Growing Enthusiasts up to 40% on their Power Usage. 2Health News:Hot States for Medical Careers: Healthcare Staffing Agency Aureus Medical Releases Online Search Results 2Health News:PREVENT Life Safety Moves to New Office in Rancho Cucamonga 2Health News:Smith & Jones Publishes 2015 Website Design White Paper 2
... pharmaceutical community, VIENNA, Va., Feb. 11 ... http://www.convera.com, a leading provider of vertical,search ... of,PharmaLiveSearch.com, a vertical search site specific to ... with Canon,Communications Pharmaceutical Media Group., ...
... of Directors as Chairman, NASHVILLE, Tenn., Feb. ... General Atlantic LLC (General,Atlantic) and affiliates of Hellman ... interests in Emdeon held by HLTH Corporation (Nasdaq:,HLTH). ... from HLTH in,November 2006., Emdeon also announced ...
... #1 FOR IMMEDIATE RELEASE , Recordable ... , Move over, compact discs, DVDs, and hard drives. ... protein-based memory device that could provide an alternative to ... approaching their memory storage capacities. Their study is scheduled ...
... Corporation,of America (Nasdaq: DCAI ) announced the ... Delaware County, Ohio which began construction,late last year, ... Everett commented, "Our newest facility in Ohio,opened earlier ... zero,deficiencies. The facility is in partnership with physicians ...
... to complementary or alternative medicine may not be accurate, ... -- Just 5 percent of Web pages devoted to ... complementary or alternative medicine are 15 times more likely ... a new study says. , Moreover, standard measures of ...
... to improve,prostate cancer imaging, WASHINGTON, Feb. 11 ... the Department of Health and Human,Services (HHS) and ... high priority" in the current for research and ... treatment of prostate,cancer. Such a federal investment in ...
Cached Medicine News:Health News:Convera(R) and Canon Communications Launch PharmaLiveSearch.com 2Health News:Convera(R) and Canon Communications Launch PharmaLiveSearch.com 3Health News:General Atlantic and Hellman & Friedman Purchase HLTH Corporation's Remaining Interest in Emdeon 2Health News:General Atlantic and Hellman & Friedman Purchase HLTH Corporation's Remaining Interest in Emdeon 3Health News:General Atlantic and Hellman & Friedman Purchase HLTH Corporation's Remaining Interest in Emdeon 4Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 2Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 3Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 4Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 5Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 6Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 7Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 8Health News:American Chemical Society's Weekly PressPac -- Feb. 6, 2008 9Health News:Dialysis Corporation of America Announces Opening of New Dialysis Center in Ohio 2Health News:Most Breast Cancer Web Pages Contain Reliable Information 2Health News:U.S. Representatives Urge Critical Improvements in Prostate Cancer Detection 2Health News:U.S. Representatives Urge Critical Improvements in Prostate Cancer Detection 3Health News:U.S. Representatives Urge Critical Improvements in Prostate Cancer Detection 4
Corning 7078A multi-pack plugged capacity 5 mL...
Calibrated"to deliver"with blow-out, andpacked in a flip-top canister to keep the pipets racked. Feature: subdivision 0.1 mL volume 5.0 mL...
Corning 7077B L 215 mm volume 5.0 0.1 mL...
... is a new product number, ... product number. If showing no ... the old Sigma-Aldrich number (Z37,160-2) ... assistance. Color: colour-coded ...
Medicine Products: